NEWS & UPDATES
1994
Jan 2026 – Initiated statutory tax preparation and compliance filings following the company’s 18-month operational milestone.
As the company reached its 18-month mark of operation, January 2026 represented an important administrative and compliance milestone. Preparations were initiated for statutory tax filing and related financial reporting, reflecting the company's transition from early-stage setup to ongoing operations. This step supports regulatory compliance, financial transparency, and the continued development of sustainable business activities.
2001
2007
2012
2017
NEWS & UPDATES
1994
Dec 2025 – Initiated procurement of commercial insurance coverage to support U.S.–Japan cross-border operations, including protection for directors and senior officers against business-related claims.
Because our activities span multiple countries and involve cross-border partnerships and leadership teams, we take a proactive approach to risk management. Seeking commercial insurance allows us to operate responsibly while supporting our people and collaborations.
2001
Dec 2025 – Collaboration with Hawkeye Bio confirmed; preparation for media coverage underway.
Dec 2025 – Strategic collaboration in regenerative medicine established with Japanese partners, and formal agreements executed.
In December 2025, the company confirmed a collaboration with Hawkeye Bio while also establishing a strategic partnership in regenerative medicine with Japanese partners. During this period, formal agreements were executed and preparations began for coordinated media coverage, reflecting growing cross-border collaboration and increasing visibility of the company’s initiatives.
2007
Nov 2025 – Participated in the International Functional Medicine Innovation Conference in Beijing.
Nov 2025 – Participated in the China Maternal and Child Health Development Conference in Xiamen.
In November 2025, the company participated in the International Functional Medicine Innovation Conference in Beijing and the China Maternal and Child Health Development Conference in Xiamen. These engagements provided valuable opportunities to observe emerging trends, exchange perspectives, and better understand developments across the Greater China healthcare and life sciences landscape.
2012
Jul 2025 – Initial collaboration discussions held with a Las Vegas–based IVF center. (U.S.)
Jul 2025 – Partnership discussions commenced with Hawkeye Bio (U.S.).
Mar 2025 – Initial engagement initiated with Fujita Health University (Japan).
Between March and July 2025, the company actively pursued early-stage international collaboration opportunities, including initial engagement with Fujita Health University in Japan and partnership discussions with a Las Vegas–based IVF center and Hawkeye Bio in the United States. These efforts required repeated cross-border travel, in-person meetings, and sustained follow-up, reflecting the team’s commitment to building meaningful relationships beyond Hong Kong. Rather than remaining locally focused, the company invested significant time and effort to engage directly with partners across regions and lay the groundwork for future collaboration.
2017
Sep 2024 – HSBC corporate bank account successfully opened.
Nov 2024 – MPF (Mandatory Provident Fund) account established.
Jul 2024 – Core leadership team in place.
Jun 2024 – Hong Kong entity formally established.
Mar 2025 – Virtual office secured in Hong Kong, reinforcing a light-asset operating model for international activities.
From June to November 2024, the company focused on building its operational foundation after formally establishing its Hong Kong entity. As a light-asset organization developed from the NurseKnowsNurse™ initiative, Hong Kong was chosen as a practical base for international collaboration and global activities. With founding members based locally, the company fully invested in setting up Nurse DAO Limited, forming its core leadership team, opening an HSBC corporate account, and establishing the Mandatory Provident Fund (MPF) scheme.
In March 2025, the company further formalized its local administrative presence by arranging a virtual office in Hong Kong, supporting flexible operations while maintaining a registered business address.